Using K-TRACS can help inform clinical decisions as you work to improve patient safety and promote community health.
K-TRACS patient data should be used in combination with a patient's health history and other factors to assist with clinical decision-making.
Prescribers should check K-TRACS before prescribing controlled substances to ensure patient safety and avoid overlapping prescriptions or duplicating prescriptions from other prescribers. You can also assess any concerning prescription drug patterns.
Prescriber E-Recap (PERx) is a quarterly snapshot of your prescribing practices regarding controlled substances. With this report, you can compare your prescribing history to other providers in your specialty, see aggregate patient data and monitor K-TRACS usage among your delegates.
Three-fourths of K-TRACS users are prescribers and their delegates. The number of active prescriber users, including delegates, has increased 46% from 2018 to 2021.
Prescribers and their delegates completed nearly two-thirds of all patient searches in 2021. The number of patient searches completed by prescribers and their delegates has increased nearly three-fold from 2018 to 2021.
View a variety of prescribing resources and best practices from CDC, CMS and other regulatory agencies. Review relevant resources with all prescribers in your practice or department to ensure consistency in prescribing.
The most effective screening tool for substance use disorders is SBIRT, Screening, Brief Intervention and Referral to Treatment.
The screening quickly assesses the risk of a substance use disorder and identifies the appropriate level of treatment. The brief intervention focuses on patients understanding their substance use, health impact and motivations for behavior change. The referral provides patients with access to appropriate specialty care.